Relx Plc $RELX Shares Acquired by QRG Capital Management Inc.

Key Points

• QRG Capital Management Inc. increased its stake in Relx Plc by 16.7%, owning 288,409 shares valued at approximately $15.67 million.
• A variety of institutional investors have recently adjusted their holdings, with Goldman Sachs raising its stake by 4.5% to own over 4 million shares valued at $205 million.
• Relx Plc's stock rating has mixed analyst opinions, with Wall Street Zen downgrading it to "hold," while other analysts maintain "buy" ratings, giving it a consensus rating of "Buy."

QRG Capital Management Inc. increased its position in shares of Relx Plc (NYSE:RELX - Free Report) by 16.7% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 288,409 shares of the technology company's stock after purchasing an additional 41,222 shares during the period. QRG Capital Management Inc.'s holdings in Relx were worth $15,672,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. Goldman Sachs Group Inc. raised its stake in shares of Relx by 4.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company's stock worth $205,287,000 after buying an additional 173,976 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company's stock worth $154,129,000 after acquiring an additional 234,094 shares during the period. Northern Trust Corp raised its position in Relx by 9.2% in the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company's stock worth $120,686,000 after acquiring an additional 202,509 shares in the last quarter. Natixis Advisors LLC lifted its holdings in Relx by 0.5% in the first quarter. Natixis Advisors LLC now owns 1,208,467 shares of the technology company's stock valued at $60,919,000 after acquiring an additional 5,875 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Relx by 103.4% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 444,360 shares of the technology company's stock valued at $22,400,000 after acquiring an additional 225,947 shares during the period. Hedge funds and other institutional investors own 15.02% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on RELX shares. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Kepler Capital Markets raised shares of Relx from a "hold" rating to a "strong-buy" rating in a report on Thursday, September 18th. Morgan Stanley reiterated an "overweight" rating on shares of Relx in a research report on Thursday, September 11th. Finally, Weiss Ratings restated a "buy (b)" rating on shares of Relx in a report on Saturday, September 27th. One analyst has rated the stock with a Strong Buy rating and five have given a Buy rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy".

Relx Stock Performance

Shares of RELX opened at $46.43 on Friday. Relx Plc has a 12-month low of $44.19 and a 12-month high of $56.33. The stock has a market cap of $85.09 billion, a P/E ratio of 24.96, a PEG ratio of 3.03 and a beta of 0.87. The company has a current ratio of 0.47, a quick ratio of 0.42 and a debt-to-equity ratio of 2.55. The company has a 50-day moving average of $47.85 and a two-hundred day moving average of $50.96.

Relx Cuts Dividend

The business also recently disclosed a semi-annual dividend, which was paid on Tuesday, September 16th. Investors of record on Friday, August 8th were given a dividend of $0.2634 per share. This represents a dividend yield of 170.0%. The ex-dividend date was Friday, August 8th. Relx's payout ratio is currently 28.49%.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.